In vivo MR imaging of magnetically labeled mesenchymal stem cells transplanted into rat liver through hepatic arterial injection

Contrast Media and Molecular Imaging

Volumn 3, Issue 2, 2008, Pages 72-77

  Cai, Jinhua ^a,c   Zhang, Xuemei ^b   Wang, Xin ^b   Li, Chuan ^b   Liu, Guanxin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c NONE   (China)

Author keywords

Animal experiment; Liver; Magnetic resonance; Mesenchymal stem cells; Superparamagnetic iron oxides

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; FERRIC FERROCYANIDE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LABELING; CONTROLLED STUDY; CYTOPLASM; DRUG DISTRIBUTION; FLUORESCENCE MICROSCOPY; HEPATIC ARTERY; KIDNEY PARENCHYMA; LIVER NECROSIS; LIVER PARENCHYMA; LUNG PARENCHYMA; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE TISSUE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RAT; SIGNAL NOISE RATIO; SPLEEN; STAINING; TISSUE DISTRIBUTION;

EID: 44249118084     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.231     Document Type: Article

References (30)

1. 1 Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003 422: 901–904.
2. 2 Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, et al. Effects of intracoronary infusion of peripheral blood stem‐cells mobilized with granulocyte‐colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial. Lancet 2004 363: 751–756.
3. 3 Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Inqwall JS, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 2003 9: 1195–1201.
4. 4 Josephson L, Tung CH, Moore A, Weissleder R. High‐efficiency intracellular magnetic labeling with novel superparamagnetic‐tat peptide conjugates. Bioconjug. Chem. 1999 10: 186–191.
5. 5 Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, et al. Tat peptide‐derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 2000 18: 410–414.
6. 6 Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003 228: 480–487.
7. 7 Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003 229: 838–846.
8. 8 Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 2001 19: 1141–1147.
9. 9 Lee LH, Bulte JW, Schweinhardt P, Douqlas T, Trifunovski A, Hofstetter C, Olson L, Spenqer C. In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp. Neurol. 2004 187: 509–516.
10. 10 Bulte JW, Ben‐Hur T, Miller BR, Mizrachi‐Kol R, Einstein O, Reinhartz E, et al. MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain. Magn. Reson. Med. 2003 50: 201–205.
11. 11 Arbab AS, Jordan EK, Wilson LB, Yocum GT, Lewis BK, Frank JA. In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum. Gene Ther. 2004 15: 351–360.
12. 12 Rice HE, Hsu EW, Sheng H, Evenson DA, Freemerman AJ, Safford KM, et al. Superparamagnetic iron oxide labeling and transplantation of adipose‐derived stem cells in middle cerebral artery occlusion‐injured mice. AJR Am. J. Roentgenol. 2007 188: 1101–1108.
13. 13 Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003 107: 2290–2293.
14. 14 Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003 108: 1009–1014.
15. 15 Weber A, Pedrosa I, Kawammoto A, Himes N, Munasinghe J, Asahara T, et al. Magnetic resonance mapping of transplanted endothelial progenitor cells for therapeutic neovascularization in ischemic heart disease. Eur. J. Cardiothorac. Surg. 2004 26: 137–143.
16. 16 Bos C, Delmas Y, Desmouliere A, Solanilla A, Hauger O, Grosset C, et al. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 2004 233: 781–789.
17. 17 Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5‐azacytidine. Muscle Nerve 1995 18: 1417–1426.
18. 18 Cai JH, Feng GS, Wang X, Liu GX, Zhang DY, Hu LY. Tracing magnetically labeled mesenchymal stem cells transplanted into livers by MRI. Zhonghua Gan Zang Bing Za Zhi 2007 15: 170–173.
19. 19 Bulte JW, Zhang S, Van Gelderen P, Herynek V, Jordan EK, Duncan ID, et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc. Natl. Acad. Sci. USA 1999 96: 15256–15261.
20. 20 Hoehn M, Kustermann E, Blunk J, Wiedermann K, Trapp T, Wecher S, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl. Acad. Sci. USA 2002 99: 16267–16272.
21. 21 Modo M, Cash D, Mellodew K, Williams SC, Fraser SE, Meade TJ, et al. Tracking transplanted stem cell migration using bifunctional, contrast agent‐enhanced, magnetic resonance imaging. Neuroimage 2002 17: 803–811.
22. 22 Himes N, Min JY, Lee R, Brown C, Shea J, Huang X, et al. In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction. Magn. Reson. Med. 2004 52: 1214–1219.
23. 23 Dick AJ, Guttman MA, Raman VK, Peters DS, Pessanha BS, Hill JM, et al. Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine. Circulation 2003 108: 2899–2904.
24. 24 Ittrich H, Lange C, Togel F, Zander AR, Dahnke H, Westenfelder C, et al. In vivo magnetic resonance imaging of iron oxide‐labeled, arterially‐injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3 T. J. Magn. Reson. Imag. 2007 25: 1179–1191.
25. 25 Daldrup‐Link HE, Rudelius M, Piontek G, Metz S, Brauer R, Debus G, et al. Migration of iron oxide‐labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5‐T MR imaging equipment. Radiology 2005 234: 197–205.
26. 26 Hauger O, Frost EE, Van Heeswijk R, Deminiere C, Xue R, Delmas Y, et al. MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. Radiology 2006 238: 200–210.
27. 27 Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira‐Hansen M, Bekele BN, et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted‐delivery vehicles for anticancer agents. J. Natl. Cancer Inst. 2004 96: 1593–1603.
28. 28 Chen XC, Wang R, Zhao X, Wei YQ, Hu M, Wang YS, et al. Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12‐gene‐engineered MSCs. Carcinogenesis 2006 27: 2434–2441.
29. 29 Hung SC, Deng WP, Yang WK, Liu RS, Lee CC, Su TC, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin. Cancer Res. 2005 11: 7749–7756.
30. 30 Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, Fine HA, et al. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005 105: 420–425.